[Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
van Zwieten
P A
PA
Academisch Medisch Centrum, afd. Farmacotherapie en Cardiologie, Amsterdam.
D003846:Deoxyepinephrine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D014665:Vasodilator Agents / Q000627:therapeutic use
D015259:Dopamine Agents; D014665:Vasodilator Agents; C046318:dopexamine; D004280:Dobutamine; C023487:ibopamine; D003846:Deoxyepinephrine; D004298:Dopamine